| Maria Perez, CLINICAL NURSE SPECI | |
|
Calle Antares 4427, Urbanizacion Star Light, Ponce, PR 00717 | |
| (787) 641-7582 | |
| Not Available |
| Full Name | Maria Perez |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist - Medical-surgical |
| Location | Calle Antares 4427, Ponce, Puerto Rico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063425718 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SM0705X | Clinical Nurse Specialist - Medical-surgical | 018192 (Puerto Rico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Maria Perez, CLINICAL NURSE SPECI 4427 Calle Antares, Ponce, PR 00717-1465 Ph: (787) 641-7582 | Maria Perez, CLINICAL NURSE SPECI Calle Antares 4427, Urbanizacion Star Light, Ponce, PR 00717 Ph: (787) 641-7582 |
News Archive
Presently, there is a need to develop improved versions of COVID-19 vaccines that are effective against the SARS-CoV-2 variants of concern (VOC) and can confer long-term protection. Considering the need of the hour, scientists from the University of Sydney in Australia have generated a new COVID-19 vaccine CoVac-II and evaluated its effect against COVID-19 strains. The findings from this study are published on the bioRxiv* preprint server while awaiting peer review.
For high-risk geriatric patients, improved palliative care that is matched to their changing needs at home can reduce emergency room visits, reduce health care costs, and improve overall care. Current gaps in policy and practice that block implementation of these beneficial customized care models are presented in the article "Research Priorities in Geriatric Palliative Care: Policy Initiatives," published in Journal of Palliative Medicine, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Restored Hearing, a company established by physics students from University College Dublin and the University of Edinburgh, is preparing to launch a series of clinical trials in Edinburgh to see if its 'sound therapy' for temporary tinnitus can be used to treat a more serious permanent 'ringing in the ears'.
T2 Biosystems, Inc. a company developing innovative diagnostic products to improve patient health, today announced that data on its T2Candida Panel was presented today at the Interscience Conference on Antimicrobial Agents and Chemotherapy and the International Society of Chemotherapy joint meeting in San Diego, CA.
› Verified 9 days ago